ZAROXOLYN DIN 00888419
Health Canada record
| Active ingredient(s) | METOLAZONE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03BA08 METOLAZONE |
| Original market date | 22-Aug-1997 |
| Current status date | 22-Jul-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
Aventis Pharma Manufacturing Pte Ltd. — licence , not currently licensed, last inspection rating C (2024-05-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METOLAZONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00888400 | ZAROXOLYN | SANOFI-AVENTIS CANADA INC | Tablet | METOLAZONE 2.5 MG | Marketed |
| 00888427 | ZAROXOLYN TAB 10MG | RHONE-POULENC RORER CANADA INC. | Tablet | METOLAZONE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1277 | 2000-12-01 | New Drug Submission (NDS) |
International API supply for METOLAZONE
3 valid EDQM Certificates of Suitability from 3 holders. 5 active FDA Drug Master Files.
Request a quote for ZAROXOLYN